Revenue | ₹12.16Cr |
Net Profits | ₹0.59Cr |
Net Profit Margins | -4.85% |
Bafna Pharmaceuticals Ltd’s revenue jumped 38.18% since last year same period to ₹12.16Cr in the Q2 2019-2020. On a quarterly growth basis, Bafna Pharmaceuticals Ltd has generated 70.07% jump in its revenue since last 3-months.
Bafna Pharmaceuticals Ltd’s net profit jumped 53.91% since last year same period to ₹0.59Cr in the Q2 2019-2020. On a quarterly growth basis, Bafna Pharmaceuticals Ltd has generated 72.3% jump in its net profits since last 3-months.
Bafna Pharmaceuticals Ltd’s net profit margin jumped 66.64% since last year same period to -4.85% in the Q2 2019-2020. On a quarterly growth basis, Bafna Pharmaceuticals Ltd has generated 83.71% jump in its net profit margins since last 3-months.
The revenue for Bafna Pharmaceuticals Ltd in the Q2 results 2019 was ₹12.16Cr.
The net profit for Bafna Pharmaceuticals Ltd in the Q2 results 2019 was ₹0.59Cr.
The net profit margin for Bafna Pharmaceuticals Ltd in the Q2 results 2019 was -4.85%.
The revenue for Bafna Pharmaceuticals Ltd in the Q2 results 2018 was ₹8.80Cr.
The net profit for Bafna Pharmaceuticals Ltd in the Q2 results 2018 was ₹-1.28Cr.
The net profit margin for Bafna Pharmaceuticals Ltd in the Q2 results 2018 was -14.55%.